Total Payments
$347,231
2024 Payments
$37,925
Companies
38
Transactions
729
Medicare Patients
928
Medicare Billing
$90,738
Payment Breakdown by Category
Other$297,557 (85.7%)
Consulting$21,020 (6.1%)
Travel$14,951 (4.3%)
Food & Beverage$12,678 (3.7%)
Research$793.24 (0.2%)
Education$231.88 (0.1%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $293,028 | 179 | 84.4% |
| Consulting Fee | $21,020 | 13 | 6.1% |
| Travel and Lodging | $14,951 | 45 | 4.3% |
| Food and Beverage | $12,678 | 480 | 3.7% |
| Honoraria | $4,488 | 2 | 1.3% |
| Unspecified | $793.24 | 3 | 0.2% |
| Education | $231.88 | 6 | 0.1% |
| Grant | $41.50 | 1 | 0.0% |
Payments by Type
General
$346,438
726 transactions
Research
$793.24
3 transactions
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ABBVIE INC. | $103,410 | 177 | $0 (2024) |
| Amgen Inc. | $74,627 | 102 | $0 (2023) |
| Allergan, Inc. | $69,542 | 149 | $0 (2022) |
| Lilly USA, LLC | $38,179 | 108 | $0 (2024) |
| Teva Pharmaceuticals USA, Inc. | $37,756 | 64 | $0 (2022) |
| Novo Nordisk Inc | $9,989 | 11 | $0 (2023) |
| Upsher-Smith Laboratories LLC | $4,440 | 3 | $0 (2017) |
| Avanir Pharmaceuticals, Inc. | $4,002 | 7 | $0 (2019) |
| Lundbeck LLC | $1,580 | 6 | $0 (2022) |
| Biohaven Pharmaceutical Holding Company Ltd. | $1,146 | 2 | $0 (2022) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $37,925 | 64 | ABBVIE INC. ($37,843) |
| 2023 | $12,511 | 49 | AbbVie Inc. ($12,099) |
| 2022 | $43,773 | 92 | ABBVIE INC. ($30,658) |
| 2021 | $58,099 | 107 | AbbVie Inc. ($22,809) |
| 2020 | $60,948 | 130 | Allergan, Inc. ($27,563) |
| 2019 | $80,322 | 168 | Amgen Inc. ($30,178) |
| 2018 | $41,512 | 92 | Amgen Inc. ($16,712) |
| 2017 | $12,141 | 27 | Upsher-Smith Laboratories LLC ($4,440) |
All Payment Transactions
729 individual payment records from CMS Open Payments — Page 1 of 30
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/17/2024 | ABBVIE INC. | BOTOX (Biological), QULIPTA | Food and Beverage | In-kind items and services | $14.71 | General |
| Category: BOTOX THERAPEUTIC | ||||||
| 12/05/2024 | ABBVIE INC. | BOTOX (Biological), QULIPTA | Food and Beverage | In-kind items and services | $10.09 | General |
| Category: BOTOX THERAPEUTIC | ||||||
| 11/21/2024 | ABBVIE INC. | BOTOX (Biological), QULIPTA | Food and Beverage | In-kind items and services | $19.00 | General |
| Category: BOTOX THERAPEUTIC | ||||||
| 11/07/2024 | ABBVIE INC. | QULIPTA (Drug) | Food and Beverage | In-kind items and services | $15.29 | General |
| Category: NEUROSCIENCE | ||||||
| 11/05/2024 | ABBVIE INC. | BOTOX (Biological), QULIPTA | Food and Beverage | In-kind items and services | $9.36 | General |
| Category: BOTOX THERAPEUTIC | ||||||
| 10/30/2024 | ABBVIE INC. | QULIPTA (Drug) | Food and Beverage | In-kind items and services | $17.78 | General |
| Category: NEUROSCIENCE | ||||||
| 10/29/2024 | ABBVIE INC. | QULIPTA (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $2,625.00 | General |
| Category: NEUROSCIENCE | ||||||
| 10/23/2024 | ABBVIE INC. | QULIPTA (Drug) | Food and Beverage | In-kind items and services | $13.65 | General |
| Category: NEUROSCIENCE | ||||||
| 10/16/2024 | ABBVIE INC. | UBRELVY (Drug), QULIPTA | Food and Beverage | In-kind items and services | $25.54 | General |
| Category: NEUROSCIENCE | ||||||
| 10/16/2024 | ABBVIE INC. | QULIPTA (Drug) | Food and Beverage | In-kind items and services | $8.20 | General |
| Category: NEUROSCIENCE | ||||||
| 10/16/2024 | ABBVIE INC. | QULIPTA (Drug) | Food and Beverage | In-kind items and services | $0.01 | General |
| Category: NEUROSCIENCE | ||||||
| 10/10/2024 | ABBVIE INC. | QULIPTA (Drug) | Food and Beverage | In-kind items and services | $8.53 | General |
| Category: NEUROSCIENCE | ||||||
| 10/09/2024 | ABBVIE INC. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $36.85 | General |
| Category: NEUROSCIENCE | ||||||
| 10/08/2024 | ABBVIE INC. | UBRELVY (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $2,625.00 | General |
| Category: NEUROSCIENCE | ||||||
| 10/02/2024 | Boston Scientific Corporation | — | Food and Beverage | In-kind items and services | $23.39 | General |
| Category: General - Thrombectomy_PI | ||||||
| 10/02/2024 | ABBVIE INC. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $12.23 | General |
| Category: BOTOX THERAPEUTIC | ||||||
| 09/26/2024 | ABBVIE INC. | BOTOX (Biological), QULIPTA | Food and Beverage | In-kind items and services | $9.91 | General |
| Category: BOTOX THERAPEUTIC | ||||||
| 09/19/2024 | ABBVIE INC. | UBRELVY (Drug), QULIPTA | Food and Beverage | In-kind items and services | $24.94 | General |
| Category: NEUROSCIENCE | ||||||
| 09/12/2024 | ABBVIE INC. | BOTOX (Biological), QULIPTA | Food and Beverage | In-kind items and services | $13.36 | General |
| Category: BOTOX THERAPEUTIC | ||||||
| 09/11/2024 | ABBVIE INC. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $20.77 | General |
| Category: NEUROSCIENCE | ||||||
| 09/11/2024 | ABBVIE INC. | QULIPTA (Drug), BOTOX | Food and Beverage | In-kind items and services | $11.90 | General |
| Category: NEUROSCIENCE | ||||||
| 09/04/2024 | ABBVIE INC. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $33.06 | General |
| Category: BOTOX THERAPEUTIC | ||||||
| 08/14/2024 | ABBVIE INC. | UBRELVY (Drug), QULIPTA | Food and Beverage | In-kind items and services | $26.33 | General |
| Category: NEUROSCIENCE | ||||||
| 08/01/2024 | ABBVIE INC. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $20.39 | General |
| Category: NEUROSCIENCE | ||||||
| 07/25/2024 | ABBVIE INC. | QULIPTA (Drug), BOTOX | Food and Beverage | In-kind items and services | $12.76 | General |
| Category: NEUROSCIENCE | ||||||
Research Studies & Clinical Trials
| Study Name | Company | Amount | Records |
|---|---|---|---|
| PEDIATRIC OPTIONS FOR MIGRAINE RELIEF A RANDOMIZED, DOUBLE BLIND, PLACEBO CONTROLLED STUDY OF LASMIDITAN FOR ACUTE TREATMENT OF MIGRAINE PIONEER PEDS1 | Eli Lilly and Company | $793.24 | 3 |
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 6 | 235 | 334 | $105,624 | $26,154 |
| 2022 | 4 | 245 | 322 | $88,317 | $23,947 |
| 2021 | 5 | 209 | 289 | $68,849 | $21,986 |
| 2020 | 5 | 239 | 317 | $68,452 | $18,651 |
Total Patients
928
Total Services
1,262
Medicare Billing
$90,738
Procedure Codes
21
All Medicare Procedures & Services
21 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Facility | 2023 | 99 | 99 | $28,865 | $9,113 | 31.6% |
| 64615 | Injection of chemical for paralysis of facial and neck nerve muscles on both sides of face | Facility | 2023 | 32 | 104 | $46,958 | $8,119 | 17.3% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2023 | 54 | 76 | $15,922 | $4,594 | 28.9% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Facility | 2023 | 14 | 14 | $5,542 | $1,771 | 32.0% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Facility | 2023 | 15 | 15 | $4,641 | $1,409 | 30.4% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Facility | 2023 | 21 | 26 | $3,696 | $1,147 | 31.0% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Facility | 2022 | 113 | 113 | $31,230 | $9,769 | 31.3% |
| 64615 | Injection of chemical for paralysis of facial and neck nerve muscles on both sides of face | Facility | 2022 | 26 | 77 | $35,425 | $6,621 | 18.7% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2022 | 61 | 81 | $14,507 | $5,163 | 35.6% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Facility | 2022 | 34 | 38 | $4,410 | $1,628 | 36.9% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 11 | 13 | $2,745 | $765.19 | 27.9% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Facility | 2021 | 83 | 119 | $17,942 | $8,443 | 47.1% |
| 99204 | New patient outpatient visit, total time 45-59 minutes | Facility | 2021 | 57 | 57 | $14,448 | $4,923 | 34.1% |
| 64615 | Injection of chemical for destruction of facial and neck nerve muscles on both sides of face | Facility | 2021 | 20 | 57 | $26,790 | $4,835 | 18.0% |
| 99223 | Initial hospital inpatient care, typically 70 minutes per day | Facility | 2021 | 15 | 15 | $5,685 | $2,054 | 36.1% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Facility | 2021 | 34 | 41 | $3,984 | $1,731 | 43.4% |
| 64615 | Injection of chemical for destruction of facial and neck nerve muscles on both sides of face | Facility | 2020 | 26 | 67 | $31,490 | $5,492 | 17.4% |
| 99204 | New patient office or other outpatient visit, typically 45 minutes | Facility | 2020 | 61 | 61 | $15,250 | $5,235 | 34.3% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Facility | 2020 | 76 | 100 | $14,800 | $5,216 | 35.2% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Facility | 2020 | 45 | 55 | $5,280 | $2,033 | 38.5% |
| 99441 | Physician telephone patient service, 5-10 minutes of medical discussion | Facility | 2020 | 31 | 34 | $1,632 | $675.66 | 41.4% |
About Dr. Ryan Smith, D.O
Dr. Ryan Smith, D.O is a Neurology healthcare provider based in Lansing, Michigan. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 05/28/2010. The National Provider Identifier (NPI) number assigned to this provider is 1750600797.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Ryan Smith, D.O has received a total of $347,231 in payments from pharmaceutical and medical device companies, with $37,925 received in 2024. These payments were reported across 729 transactions from 38 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($293,028).
As a Medicare-enrolled provider, Smith has provided services to 928 Medicare beneficiaries, totaling 1,262 services with total Medicare billing of $90,738. Data is available for 4 years (2020–2023), covering 21 distinct procedure/service records.
Ad
Practice Information
- Specialty Neurology
- Location Lansing, MI
- Active Since 05/28/2010
- Last Updated 05/28/2010
- Taxonomy Code 2084N0400X
- Entity Type Individual
- NPI Number 1750600797
Products in Payments
- Aimovig (Biological) $73,652
- UBRELVY (Drug) $67,882
- BOTOX (Biological) $60,908
- QULIPTA (Drug) $25,503
- AJOVY (Drug) $20,504
- EMGALITY (Drug) $18,095
- BOTOX (Drug) $15,509
- AJOVY (Biological) $12,344
- REYVOW (Drug) $8,063
- QUDEXY XR Topiramate Extended Release Capsules (Drug) $4,440
- ONZETRA Xsail (Drug) $3,978
- BOTOX CHRONIC MIGRAINE (Drug) $3,064
- VYEPTI (Biological) $1,561
- NURTEC ODT (Drug) $1,180
- TROKENDI XR (Drug) $354.10
- TECFIDERA (Drug) $118.35
- TYSABRI (Biological) $102.92
- OCREVUS (Biological) $95.41
- NUPLAZID (Drug) $88.65
- ZEPOSIA (Drug) $77.29
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Neurology Doctors in Lansing
Karam Gagi, Md, MD
Neurology — Payments: $2,387
Neurology $2,387
Dr. Nicholas Scapini, Do, DO
Neurology — Payments: $1,925
Neurology $1,925
Melody Merati, Do, DO
Neurology — Payments: $1,839
Neurology $1,839
Melissa Patricia Bucheli, Do, DO
Neurology — Payments: $1,657
Neurology $1,657
Dr. Ryan Skowronek, Do, DO
Neurology — Payments: $1,402
Neurology $1,402
Serena Soleimani, Do, DO
Neurology — Payments: $957.99
Neurology $957.99